Filing Details

Accession Number:
0001104659-15-044670
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-10 18:00:33
Reporting Period:
2015-06-08
Filing Date:
2015-06-10
Accepted Time:
2015-06-10 18:00:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185039 Richard Aldrich C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-08 7,000 $10.85 7,000 No 4 M Direct
Common Stock Disposition 2015-06-08 6,896 $55.65 104 No 4 S Direct
Common Stock Disposition 2015-06-08 104 $56.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-06-08 7,000 $0.00 7,000 $10.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,000 2025-06-09 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $27.05 2015-01-28 2024-01-27 10,000 10,000 Direct
Common Stock Stock Option (Right to Buy) $51.00 2016-01-02 2025-01-01 12,000 12,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-01-27 10,000 10,000 Direct
2025-01-01 12,000 12,000 Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person.
  2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.05 to $56.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.05 to $56.08 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.